ARK Genomic Valuation

Etfs . Switzerland . 
Etf . ARK Genomic
ARKG Etf   4.38  0.03  0.68%   
the entity is overvaluedARK Genomic shows a prevailing Real Value of USD4.04 per share. The current price of the entity is USD4.38.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY